Zhiguo Liu

Zhiguo Liu

Auto-generated profile, based on publicly available information

Zhiguo Liu

Wenzhou Medical University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CQChenyu Qiu
Chenyu Qiu
TZTingting Zhang
Tingting Zhang
WZWenxin Zhang
Wenxin Zhang
LZLina Zhou
Lina Zhou
BYBin Yu
Bin Yu
GLGuang Liang
Guang Liang
Licochalcone A (LicA), a flavonoid isolated from the famous Chinese medicinal herb Glycyrrhiza uralensis Fisch, has wide spectrum of pharmacological activities. In this study, the anti-cancer effects and potential mechanisms of LicA in non-small cell lung cancer (NSCLC) cells were studied. LicA decreased cell viability and induced apoptosis in a dose-dependent manner in NSCLC cells. LicA inhibited lung cancer cells growth by blocking cell cycle progression at the G2/M transition and inducing apoptosis. LicA treatment decreased the expression of MDM2, Cyclin B1, Cdc2 and Cdc25C in H460 and A549 cancer cell lines. In addition, LicA induced caspase-3 activation and poly-ADP-ribose polymerase (PARP) cleavage, which displayed features of apoptotic signals. Furthermore, LicA increased the expression of endoplasmic reticulum (ER) stress related proteins, such as p-EIF2α and ATF4. These data provide evidence that LicA has the potential to be used in the treatment of lung cancer.

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HZHeping Zhu
Heping Zhu
TXTingting Xu
Tingting Xu
CQChenyu Qiu
Chenyu Qiu
BWBeibei Wu
Beibei Wu
YZYali Zhang
Yali Zhang
GLGuang Liang
Guang Liang

18 April 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZLZhiguo Liu
Zhiguo Liu
LCLingfeng Chen
Lingfeng Chen
PYPengtian Yu
Pengtian Yu
YZYali Zhang
Yali Zhang
BFBo Fang
Bo Fang
GLGuang Liang
Guang Liang

1 April 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JQJianchang Qian
Jianchang Qian
XCXianxin Chen
Xianxin Chen
SSSheng Shu
Sheng Shu
WZWenxin Zhang
Wenxin Zhang
BFBo Fang
Bo Fang
GLGuang Liang
Guang Liang

24 October 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZLZhiguo Liu
Zhiguo Liu
YSYusheng Sun
Yusheng Sun
LRLuqing Ren
Luqing Ren
YHYi Huang
Yi Huang
YCYuepiao Cai
Yuepiao Cai
YWYi Wang
Yi Wang
Background: Recent advances have highlighted the importance of the endoplasmic reticulum (ER) in cell death processes. Pharmacological interventions that effectively enhance tumor cell death through activating ER stress have attracted a great deal of attention for anti-cancer therapy. Methods: A bio-evaluation on 113 curcumin analogs against four cancer cell lines was performed through MTT assay. Furthermore, real time cell assay and flow cytometer were used to evaluate the apoptotic induction of (1E,4E)-1,5-bis(5-bromo-2-ethoxyphenyl)penta-1,4-dien-3-one (B82). Western blot, RT-qPCR, and siRNA were then utilized to confirm whether B82-induced apoptosis is mediated through activating ER stress pathway. Finally, the in vivo anti-tumor effect of B82 was evaluated. Results: B82 exhibited strong anti-tumor activity in non-small cell lung cancer (NSCLC) H460 cells. Treatment with B82 significantly induced apoptosis in H460 cells in vitro and inhibited H460 tumor growth in vivo. Further studies demonstrated that the B82-induced apoptosis is mediated by activating ER stress both in vitro and in vivo. Conclusions: A new monocarbonyl analog of curcumin, B82, exhibited anti-tumor effects on H460 cells via an ER stress-mediated mechanism. B82 could be further explored as a potential anticancer agent for the treatment of NSCLC.

1 January 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
PHPeng-Chao Huo
Peng-Chao Huo
QHQing Hu
Qing Hu
SSSheng Shu
Sheng Shu
QZQi-Hang Zhou
Qi-Hang Zhou
RHRong-Jing He
Rong-Jing He
Guang-Bo GeGuang-Bo Ge
Guang-Bo Ge